HB225
WWW Version
The hyperlink to a bill draft that precedes a summary contains the most recent version (Introduced/GA/Enacted) of the bill. If the session has ended, the hyperlink contains the latest version of the bill at the time of sine die adjournment. Note that the summary pertains to the bill as introduced, which is often different from the most recent version.
HB 225/CI/LM (BR 1170) - J. Donohue, R. Adkins, G. Brown Jr, T. Burch, M. Cantrell, K. Flood, A. Gentry, D. Graham, C. Harris, A. Hatton, D. Horlander, J. Jenkins, J. Kay, D. Keene, M. Marzian, R. Meeks, R. Meyer, C. Miller, R. Nelson, R. Rand, J. Richards, S. Riggs, D. Schamore, A. Simpson, J. Sims Jr, W. Stone, G. Watkins, J. Wayne, S. Westrom
AN ACT relating to the advertising of opiate and opioid agonist drugs.
Create a new section of KRS Chapter 218A to prohibit the advertising of opiate and opioid agonist drugs.
Jan 22, 2018 - introduced in House
Jan 24, 2018 - to Judiciary (H)
Feb 20, 2018 - posted in committee